Last reviewed · How we verify
Female hypogonadism syndrome
Approved treatments
- Delestrogen · Ph Health
Delestrogen works by binding to estrogen receptors in the body, mimicking the effects of natural estrogen. - Micronor · Johnson & Johnson
ORIAHNN combines elagolix, which suppresses LH and FSH to reduce ovarian sex hormones, with estradiol and norethindrone acetate to mitigate side effects. - Noretynodrel · Pfizer
- Estrace · Pfizer
Estrace works by binding to estrogen receptors in the body, mimicking the effects of natural estrogen. - Ogen .625 · Pfizer
- Estring · Pfizer Inc.
Prevents pregnancy primarily by suppressing ovulation. - Cyklokapron · Exela Pharma
Tranexamic acid works by binding to plasminogen and preventing its conversion to plasmin, thereby inhibiting fibrinolysis. - Depoestradiol · Pfizer
- Norinyl 1+50 28-Day
- Amchafibrin · Fundación Pública Andaluza Progreso y Salud
- transamin · Erzincan Military Hospital
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Female hypogonadism syndrome patent landscape — cliff calendar, originator estates, attackable patents
- Female hypogonadism syndrome treatment landscape brief
- Female hypogonadism syndrome treatment updates RSS
Frequently asked questions about Female hypogonadism syndrome
What drugs treat Female hypogonadism syndrome?
Tracked treatments include Delestrogen, Micronor, Noretynodrel, Estrace, Ogen .625, Estring, Cyklokapron, Depoestradiol.
What is the treatment for Female hypogonadism syndrome?
Standard treatment for Female hypogonadism syndrome includes Delestrogen, Micronor, Noretynodrel, Estrace, Ogen .625. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Female hypogonadism syndrome patent cliff · Female hypogonadism syndrome CI report
- Treatment: Delestrogen · Ph Health
- Treatment: Micronor · Johnson & Johnson
- Treatment: Noretynodrel · Pfizer
- Treatment: Estrace · Pfizer
- Treatment: Ogen .625 · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing